ISRG

As of 2026-09-10, ISRG scores 43out of 100 on QNTM’s five-factor quantitative model, a low conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. ISRG trades at $360.46, 45% above the band ceiling.

ISRG scores 43 out of 100 on QNTM's five-factor model — a low-conviction reading — at 43 the factor profile is among the weaker names in the universe. Its strongest factor is quality at 59 (solid), where earnings quality and balance-sheet strength stand out, followed by sentiment at 58. The weakest is momentum at 18, where price trend is the soft spot. Among Healthcare stocks it sits in the lower 37% of Healthcare names by composite.

On valuation, ISRG is priced near the top of its recent range — the rich end on the model's valuation read. The blended composite before the macro overlay was 44. Same-sector names the model rates nearby include HALO, THC, TGTX.

This is a descriptive factor read on ISRG, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where ISRG sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for ISRG runs $163.96–$247.86. Current price $360.46 sits 45% above the band ceiling. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.